Charlemagne Capital as of June 30, 2014
Portfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 57 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Baidu Spon Adr Rep A (BIDU) | 17.8 | $22M | 120k | 187.21 | |
| Itau Unbanco Hldg Sa Spon Adr Rep Pfd (ITUB) | 15.8 | $20M | 1.4M | 14.36 | |
| Petroleo Brasileiro Sa Petro Sp Adr Non Vtg (PBR.A) | 8.4 | $11M | 675k | 15.62 | |
| Ambev Sa Sponsored Adr (ABEV) | 7.4 | $9.3M | 1.3M | 7.04 | |
| Fomento Economico Mexican S Spon Adr Units (FMX) | 5.1 | $6.4M | 68k | 93.71 | |
| Banco Bradesco S A Sp Adr Pfd New (BBD) | 5.1 | $6.4M | 438k | 14.52 | |
| New Oriental Ed & Tech Grp I Spon Adr | 4.8 | $6.0M | 227k | 26.44 | |
| Vale S A Adr (VALE) | 4.4 | $5.5M | 415k | 13.23 | |
| Grupo Televisa Sa Spon Adr Rep Ord (TV) | 4.2 | $5.3M | 155k | 34.25 | |
| Credicorp (BAP) | 3.8 | $4.8M | 31k | 155.27 | |
| Brf Sa Sponsored Adr (BRFS) | 3.6 | $4.6M | 189k | 24.26 | |
| JD Spon Adr Cl A (JD) | 3.3 | $4.1M | 145k | 28.48 | |
| Tal Ed Group Ads Repstg Com (TAL) | 2.9 | $3.6M | 133k | 27.51 | |
| Copa Holdings Sa Cl A (CPA) | 2.7 | $3.3M | 24k | 142.40 | |
| Grana Y Montero S A A Sponsored Adr | 2.3 | $2.9M | 162k | 18.04 | |
| Ultrapar Participacoes S A Sp Adr Rep Com (UGP) | 1.7 | $2.1M | 90k | 23.61 | |
| Avianca Hldgs Sa Spon Adr Rep Pfd | 1.3 | $1.6M | 101k | 16.07 | |
| Johnson & Johnson (JNJ) | 0.5 | $657k | 6.3k | 104.63 | |
| Cosan Shs A | 0.5 | $603k | 45k | 13.54 | |
| Petro Brasileiro Sa Petro Sponsored Adr (PBR) | 0.5 | $598k | 41k | 14.64 | |
| Pfizer (PFE) | 0.4 | $550k | 19k | 29.68 | |
| Merck & Co (MRK) | 0.3 | $384k | 6.6k | 57.75 | |
| Abbvie (ABBV) | 0.2 | $301k | 5.3k | 56.45 | |
| Gilead Sciences (GILD) | 0.2 | $242k | 2.9k | 83.16 | |
| Allergan | 0.2 | $241k | 1.4k | 169.72 | |
| Orexigen Therapeutics | 0.2 | $217k | 35k | 6.16 | |
| Bristol Myers Squibb (BMY) | 0.2 | $214k | 4.4k | 48.34 | |
| Mylan | 0.2 | $209k | 4.1k | 51.23 | |
| Insulet Corporation (PODD) | 0.2 | $193k | 4.9k | 39.65 | |
| Thermo Fisher Scientific (TMO) | 0.2 | $191k | 1.6k | 117.76 | |
| Medivation | 0.1 | $176k | 2.3k | 76.72 | |
| Medtronic | 0.1 | $173k | 2.7k | 63.65 | |
| Forest Laboratories | 0.1 | $167k | 1.7k | 99.11 | |
| Sanofi Sponsored Adr (SNY) | 0.1 | $143k | 2.7k | 52.96 | |
| Theravance | 0.1 | $135k | 4.5k | 29.79 | |
| Theravance Biopharma (TBPH) | 0.1 | $135k | 4.3k | 31.11 | |
| Amgen (AMGN) | 0.1 | $126k | 1.1k | 118.31 | |
| Becton, Dickinson and (BDX) | 0.1 | $124k | 1.1k | 118.10 | |
| Illumina (ILMN) | 0.1 | $121k | 682.00 | 177.42 | |
| Abbott Laboratories (ABT) | 0.1 | $117k | 2.9k | 40.98 | |
| Impax Laboratories | 0.1 | $86k | 2.9k | 30.02 | |
| Pharmacyclics | 0.1 | $84k | 937.00 | 89.65 | |
| Salix Pharmaceuticals | 0.1 | $84k | 681.00 | 123.35 | |
| Boston Scientific Corporation (BSX) | 0.1 | $77k | 6.1k | 12.71 | |
| Biogen Idec (BIIB) | 0.1 | $74k | 236.00 | 313.56 | |
| NPS Pharmaceuticals | 0.0 | $62k | 1.9k | 33.05 | |
| Nanostring Technologies (NSTGQ) | 0.0 | $61k | 4.1k | 14.95 | |
| Celgene Corporation | 0.0 | $60k | 696.00 | 86.21 | |
| Quintiles Transnatio Hldgs I | 0.0 | $52k | 973.00 | 53.44 | |
| Incyte Corporation (INCY) | 0.0 | $43k | 769.00 | 55.92 | |
| Cubist Pharmaceuticals | 0.0 | $43k | 612.00 | 70.26 | |
| BioMarin Pharmaceutical (BMRN) | 0.0 | $41k | 664.00 | 61.75 | |
| Stryker Corporation (SYK) | 0.0 | $41k | 482.00 | 85.06 | |
| Covance | 0.0 | $41k | 482.00 | 85.06 | |
| Genomic Health | 0.0 | $41k | 1.5k | 27.59 | |
| Regeneron Pharmaceuticals (REGN) | 0.0 | $30k | 105.00 | 285.71 | |
| Medicines Company | 0.0 | $28k | 970.00 | 28.87 |
